Characterizing molecular subtypes of high-risk nonmuscle-invasive bladder cancer in African American patients.

Authors

Stephen Williams

Stephen B. Williams

Department of Surgery, Division of Urology, The University of Texas Medical Branch, Galveston, TX

Stephen B. Williams , Sungyong You , Minhyung Kim , Steven G. Widen , Alexander Yu , Eduardo J. Eyzaguirre , Lars Dyrskjøt , David McConkey , Woonyoung Choi , Dan Theodorescu , Keith S. Chan , Yong Shan , Douglas S. Tyler , Amanda M. De Hoedt , Stephen J. Freedland

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Urothelial Carcinoma

Track

Urothelial Carcinoma

Sub Track

Translational Research, Tumor Biology, Biomarkers, and Pathology

Citation

J Clin Oncol 40, 2022 (suppl 6; abstr 527)

DOI

10.1200/JCO.2022.40.6_suppl.527

Abstract #

527

Poster Bd #

H3

Abstract Disclosures

Similar Posters

Poster

2024 ASCO Genitourinary Cancers Symposium

Population based trends in intravesical gemcitabine use among patients with high-risk non-muscle invasive bladder cancer.

Population based trends in intravesical gemcitabine use among patients with high-risk non-muscle invasive bladder cancer.

First Author: Stephen B. Williams

First Author: Shilpa Gupta